Health News Releases

  • Today February 19
September 11, 2014 17:30
Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suff
September 10, 2014 18:25
Diabetes: Boehringer Ingelheim and Eli Lilly and Company announce data on portfolio to be presented at the 50th EASD Annual Meeting
Data to be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna, Austria, will add to the extensive clinical evidence supporting the efficacy and safety prof
September 10, 2014 18:10
Nintedanib* slowed disease progression in IPF independent of patients’ lung function impairment at baseline
For media outside UK, US and Canada A pre-specified subgroup analysis from the two replicate Phase III INPULSIS™ trials, presented today at the European Respiratory Society International Congress (
September 10, 2014 17:25
TONADO™ - further lung function and quality of life benefits with tiotropium + olodaterol Respimat® FDC* in COPD
For media outside the US, the UK and Canada Data from the pivotal phase III TONADO™ studies†,1 for tiotropium + olodaterol Respimat® FDC were presented for the first time today at the European Resp
September 10, 2014 17:15
Asthma: new indication for Spiriva® (tiotropium) Respimat®* in the EU may offer millions of adults a significant advance in asthma care
For media outside the US, the UK & Canada only Boehringer Ingelheim today announced that the indication for Spiriva® (tiotropium) Respimat®* in asthma has been accepted by the regulatory authoritie
September 04, 2014 13:45
KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity
Centaur Guernsey L.P. Inc. (Centaur) announced today the launch of Acelity, effectively rebranding itself and its subsidiaries Kinetic Concepts, Inc. (KCI), LifeCell Corporation (LifeCell) and Systage
September 03, 2014 10:35
ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa® on kidney function over time compared to warfarin
Non-US/Non-UK/Non-Canadian Media New data presented today indicate that kidney function decline is less pronounced in patients with an irregular heartbeat (non-valvular atrial fibrillation, NVAF) w
September 02, 2014 09:10
Extensive experience in clinical practice and expanding research programme support use of Pradaxa® for clot prevention
For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of Pradaxa® (dabigatran etexilate) for the prevention of stroke in n
September 01, 2014 17:05
Boehringer Ingelheim to present comprehensive data supporting broad respiratory portfolio in COPD, asthma and IPF at ERS 2014
For media outside UK, US and Canada The European Respiratory Society (ERS) International Congress, in Munich, Germany, September 6-10, 2014 sets the scene for important announcements across the sub
August 29, 2014 09:00
The International Bio-Community Meets in Japan! Announcing Integrated Biotech Business Event - BioJapan 2014
BioJapan 2014 - World Business Forum - will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition Halls C & D, and Annex Hall). Comprised of exhibiti
August 27, 2014 16:00
New HeartSine AED Provides Automatic Shock Delivery
HeartSine® Technologies is pleased to announce the arrival of the samaritan® PAD 360P, a fully automatic AED (Automatic External Defibrillator) based on the company’s popular samaritan PAD 350P. Th
August 26, 2014 13:55
Centaur Announces CFO Transition Plan
Centaur Guernsey L.P. Inc. (Centaur) today announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc.,
August 25, 2014 17:35
New Pradaxa® data to be presented at the ESC Congress 2014
For Non-US/Non-UK/Non-Canadian Media New Pradaxa® (dabigatran etexilate) data for the treatment of a broad range of thromboembolic diseases will be presented at the ESC Congress 2014, 30th August -
August 21, 2014 21:00
Project Data Sphere, LLC Appoints Dr. Kald Abdallah, Chief Project Data Sphere Officer
Project Data Sphere, LLC has appointed Kald Abdallah, MD, PhD as Chief Project Data Sphere Officer, charging him with continuing the rapid development of www.ProjectDataSphere.org which is providing b
August 21, 2014 10:35
Quintiles CEO to Present at the Morgan Stanley Global Healthcare Conference
Quintiles CEO Tom Pike will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2014 in New York City at the Grand Hyatt Hotel. The Quintiles presentation will begin
August 20, 2014 13:50
Expression Analysis Announces 2014 Grant Program
Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research. I
August 20, 2014 13:40
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
Celgene Corporation (NASDAQ:CELG) today announced that results of a study evaluating the combination of REVLIMID® (lenalidomide) with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristin
August 19, 2014 17:45
First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting
INGELHEIM, Germany--(BUSINESS WIRE)-- For Non-US/Non-UK/Non-Canadian Media Boehringer Ingelheim today announces that the first patients have been enrolled in the company’s new international phas
August 19, 2014 13:40
Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd.
Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that it entered into a
August 18, 2014 14:00
Catalent Confirms the Appointment of Two Senior Healthcare Executives to Its Board of Directors
Catalent, Inc. (NYSE:CTLT), the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that it has a
Hyun Joon Moon MD, PhD.
August 12, 2014 18:06
Convenient Real No-Scalpel Vasectomy(CRNSV) techniques developed at CR CENTER in South Korea cited in an American Urology Association guideline
Vasectomy techniques and an associated device developed by Dr. Hyun Joon Moon at CR vas & microsurgery center (Seoul, South Korea) have been formally cited in an American Urology Association guideline
August 08, 2014 13:50
Terumo BCT Announces Collaboration to Evaluate Clinical Cell Production Using Quantum System
Terumo BCT’s Quantum® Cell Expansion System (http://goo.gl/O8RrZ4) is now under evaluation by Athersys, Inc., a biopharmaceutical company dedicated to the research and development of stem cell therapi
August 07, 2014 13:50
European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A
The European Commission has published approval of Octapharma’s Nuwiq® (simoctocog alfa) for the treatment and prophylaxis of bleeding in all age groups with haemophilia A (congenital factor VIII [FVII
August 01, 2014 13:45
Panasonic's Healthcare Solutions Streamline Medical Treatment
Under the theme of “Providing optimal healthcare for each individual,” Panasonic Healthcare Co., Ltd. showcased its latest solutions at the International Modern Hospital Show 2014, which was held at t
August 01, 2014 10:05
Catalent, Inc. Announces Pricing of Its Initial Public Offering
Catalent, Inc. (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the pricing of i
25 per page50 per page75 per page100 per page